Get started
CCC

CHOSA ONCOLOGY AB

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

CHOSA fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Chosa Oncology AB operates as a biotechnology company, which focuses on developing drugs related to cancer treatment. Its products include iCIP, LiPlaCis and DRP. The company was founded on January 11, 2023 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CHOSA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company